safety testing
bit.bio expands human heart cell portfolio through myriamed partnership
September 30, 2026Biotechnology, bit.bio, drug discovery, myriamed, safety testing
bit.bio has partnered with German biotechnology company myriamed to offer cryopreserved human induced pluripotent stem cell (iPSC)-derived cardiomyocytes for drug …
